Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

TEDDI: radiotherapy delivery in deep inspiration for pediatric patients - a NOPHO feasibility study.

Lundgaard AY, Hjalgrim LL, Rechner LA, Josipovic M, Joergensen M, Aznar MC, Berthelsen AK, Borgwardt L, Johansen C, Loft A, Safwat A, Vaalavirta L, Specht L, Maraldo MV.

Radiat Oncol. 2018 Mar 27;13(1):56. doi: 10.1186/s13014-018-1003-4.

2.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

3.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

4.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

5.

VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases.

Kiljunen T, Kangasmäki A, Aaltonen A, Kairemo K, Partanen K, Joensuu G, Alanko T, Vaalavirta L, Joensuu T.

Acta Oncol. 2015 Jun;54(6):847-53. doi: 10.3109/0284186X.2014.962665. Epub 2014 Oct 13.

PMID:
25307406
6.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

7.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

8.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

9.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.

10.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

11.

Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer.

Siponen ET, Vaalavirta LA, Joensuu H, Leidenius MH.

World J Surg. 2012 Feb;36(2):295-302. doi: 10.1007/s00268-011-1399-6.

PMID:
22202994
12.

Surgical management of radiation-associated cutaneous breast angiosarcoma.

Lindford A, Böhling T, Vaalavirta L, Tenhunen M, Jahkola T, Tukiainen E.

J Plast Reconstr Aesthet Surg. 2011 Aug;64(8):1036-42. doi: 10.1016/j.bjps.2011.02.014. Epub 2011 Mar 5.

PMID:
21377947
13.

Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer.

Collan J, Lundberg M, Vaalavirta L, Bäck L, Kajanti M, Mäkitie A, Tenhunen M, Saarilahti K.

Acta Oncol. 2011 Oct;50(7):1119-25. doi: 10.3109/0284186X.2010.549839. Epub 2011 Jan 19.

PMID:
21247264
14.

Ipsilateral breast recurrence after breast conserving surgery in patients with small (≤ 2cm) breast cancer treated with modern adjuvant therapies.

Siponen ET, Vaalavirta L, Joensuu H, Vironen J, Heikkilä P, Leidenius MH.

Eur J Surg Oncol. 2011 Jan;37(1):25-31. doi: 10.1016/j.ejso.2010.11.003. Epub 2010 Nov 26.

PMID:
21112722
15.

Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin.

Loimu V, Collan J, Vaalavirta L, Bäck L, Kapanen M, Mäkitie A, Tenhunen M, Saarilahti K.

Radiother Oncol. 2011 Jan;98(1):34-7. doi: 10.1016/j.radonc.2010.10.015. Epub 2010 Nov 11.

PMID:
21074875
16.

[Long-term morbidity caused by breast cancer therapy].

Leidenius M, Tasmuth T, Jahkola T, Saarto T, Utriainen M, Vaalavirta L, Tiitinen A, Idman I.

Duodecim. 2010;126(10):1217-25. Review. Finnish.

PMID:
20597351
17.

[Towards more conservative surgical and radiation therapy of breast cancer].

Leidenius M, Vaalavirta L.

Duodecim. 2010;126(10):1198-203. Review. Finnish.

PMID:
20597349
18.

Linac-based isocentric electron-photon treatment of radically operated breast carcinoma with enhanced dose uniformity in the field gap area.

Tenhunen M, Nyman H, Strengell S, Vaalavirta L.

Radiother Oncol. 2009 Oct;93(1):80-6. doi: 10.1016/j.radonc.2009.04.016. Epub 2009 May 9.

PMID:
19433339
19.

The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.

Saarilahti K, Arponen P, Vaalavirta L, Tenhunen M.

Radiother Oncol. 2008 Jun;87(3):383-90. doi: 10.1016/j.radonc.2008.04.011. Epub 2008 May 22.

PMID:
18501454
20.

The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy.

Leidenius M, Vaalavirta L, Heikkilä P, von Smitten K, Salmenkivi K.

J Surg Oncol. 2008 Jul 1;98(1):21-6. doi: 10.1002/jso.21085.

PMID:
18484087
21.

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.

Mäenpää HO, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H.

PLoS One. 2008 Apr 2;3(4):e1885. doi: 10.1371/journal.pone.0001885.

22.
23.

Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat.

Haasio K, Sopanen L, Vaalavirta L, Lindén IB, Heinonen EH.

J Neural Transm (Vienna). 2001;108(1):79-91.

PMID:
11261749
24.

Mechanisms and models of neurotoxicity of n-hexane and related solvents.

Tähti H, Engelke M, Vaalavirta L.

Arch Toxicol Suppl. 1997;19:337-45. Review. No abstract available.

PMID:
9079221
25.
26.

Effects of selected organic solvents on the astrocyte membrane ATPase in vitro.

Vaalavirta L, Tähti H.

Clin Exp Pharmacol Physiol. 1995 Apr;22(4):293-4.

PMID:
7671444
27.

Supplemental Content

Loading ...
Support Center